Aura Biosciences (AURA) Change in Accured Expenses (2020 - 2026)

Aura Biosciences' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

• Quarterly Change in Accured Expenses fell 10.91% year-over-year to -$2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 93.34% YoY) and the FY2025 annual result came in at $4.1 million, up 161.95% from the prior year.
• Change in Accured Expenses was -$2.7 million for Q1 2026 at Aura Biosciences, down from -$124000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.4 million in Q2 2025 and bottomed at -$2.9 million in Q1 2024.
• A 5-year average of $382764.7 and a median of $1.0 million in 2023 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 315.98% — and 2025, when it plunged 629.41%.
• Aura Biosciences' Change in Accured Expenses stood at -$701000.0 in 2022, then jumped by 315.98% to $1.5 million in 2023, then tumbled by 101.12% to -$17000.0 in 2024, then plunged by 629.41% to -$124000.0 in 2025, then slumped by 2113.71% to -$2.7 million in 2026.
• Business Quant data shows AURA's Change in Accured Expenses at -$2.7 million in Q1 2026, -$124000.0 in Q4 2025, and $3.3 million in Q3 2025.